Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of GP-40081 vs NovoMix 30 in Healthy Subjects
NCT04184492Phase 1Completed
- Sponsor
- Geropharm
- Start
- Apr 2019
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of biphasic insulin aspart in diabetes mellitus (DM) (2 arms), sponsored by Geropharm. Primary endpoints: Area Under the Curve (0-t) and Maximum Concentration. Started Apr 2019; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT04184492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04184492.